Email ID : 
Password : 
Forgot Your Password ? 

Only Report Titles
Titles & Keywords
NOTE: Site best viewed with Internet Explorer
  BIOTECHNOLOGY REAGENTS
A Global Strategic Business Report

This report analyzes the worldwide markets for Biotechnology Reagents in Millions of US$. The specific product segments analyzed are Cell/Tissue Culture Reagents, DNA Sequencing/Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Latin America. Annual forecasts are provided for each region for the period of 2000 through 2015. The report profiles 269 companies including many key and niche players worldwide such as Abbott Diagnostics, Applied Biosystems, Beckman Coulter, Inc., Becton Dickinson and Company, Biomerieux SA, Chemicon International, Inc., EMD Biosciences, Inc., Fitzgerald Industries International, GE Healthcare, Invitrogen Corporation, Ortho-Clinical Diagnostics, Perkin Elmer, Inc., Promega Corp., Roche Diagnostics Ltd., Siemens Healthcare Diagnostics, Inc., and Sigma – Aldrich. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

CODE:    MCP-3533  PAGES:    759
PRICE:    $3950  DATE:       October 2008
COMPANIES:  269  MARKET DATA TABLES:   126
Due to the proprietary nature, our previews are offered only to manufacturers, top-tier management consultants, investment banks, and investment research groups.

 TABLE OF CONTENTS  
  BIOTECHNOLOGY REAGENTS (Complete Report) Pages : 759   | $3950
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS5$100
   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Quantitative Techniques & Analytics.....I-3
Product Definitions and Scope of Study.....I-3
Cell & Tissue Culture Reagents.....I-3
  
   DNA Synthesis & Sequencing Reagents.....I-4
Electrophoresis Reagents.....I-4
Flow Cytometry Reagents.....I-4
Immunoassay Reagents.....I-4
  
   Liquid Chromatography Reagents.....I-5
PCR Reagents.....I-5
Protein Synthesis & Sequencing Reagents.....I-5
  
II. EXECUTIVE SUMMARY89$2250
  1. Outlook.....II-11 $100  
   Reagents Market Players Witnessing Paradigm Shift.....II-1
1$100
  2. Market Dynamics.....II-22 $200  
   Highly Automated Instrumentation Restricts Use of Reagents.....II-2
Software-Intensive Nature and High System Complexity Impedes Use of Automated
  Instruments.....II-2
Demand for Diverse Products Spurs Growth.....II-2
Increasing Use in Industrial Sector.....II-2
1$100
   Molecular Biology and Protein Synthesis Reagents – the Fastest Growing
  Segments.....II-3
Obtaining Data from Enzyme Functions.....II-3
New Economy Sees the Entry of Directed Evolution Enzymes.....II-3
1$100
  3. Biotechnology – Industry Overview.....II-43 $300  
   Growing by Leaps and Bounds.....II-4
Human Genome Mapping – A Colossal Milestone.....II-4
1$100
   High Growth Applications Spur Industry Growth.....II-5
Biochips– Promising Future.....II-5
1$100
   Convergence of Distinct Technologies.....II-6
Growing Collaboration between Biotech and Pharma Companies.....II-6
1$100
  4. Product Overview.....II-74 $400  
   A. Classification.....II-7
i. DNA Synthesis & Sequencing Reagents.....II-7
DNA: The Basis for Modern Biotechnology.....II-7
ii. PCR Reagents.....II-7
iii. Protein Synthesis & Sequencing Reagents.....II-7
1$100
   iv. Electrophoresis Reagents.....II-8
v. Bio/Chemiluminescence Reagents.....II-8
vi. Immunoassay Reagents.....II-8
Antibodies.....II-8
Monoclonal and Polyclonal Antibodies.....II-8
Types of Monoclonal Antibodies.....II-8
a. Murine Monoclonal Antibodies.....II-8
1$100
   b. Human Antibodies.....II-9
c. Chimeric Antibodies.....II-9
d. Bispecific Antibodies.....II-9
Hematology/Coagulation Reagents.....II-9
vii. Chromatography Reagents.....II-9
viii. Flow Cytometry Reagents.....II-9
1$100
   ix. Cell & Tissue Culture Reagents.....II-10
1$100
  5. Product Innovations/Introductions.....II-1115 $900  
   Beckman Coulter Introduces Two IOTest® Reagents.....II-11
Applied Biosystems Announces New Reagents.....II-11
1$100
   Calypte Biomedical Introduces New Calypte Life Sciences Family of Products.....II-12
Applied Biosystems Launches TaqMan® Cells-to-CT™ Kit Solutions.....II-12
Applied Biosystems Launches iTRAQ® Reagents.....II-12
1$100
   PerkinElmer Launches Series 275 HRes™ LC System.....II-13
Sigma-Aldrich Introduces Imprint™ ChIP Kit.....II-13
Stratagene Introduces Expanded QPCR, QRT-PCR Reagents Line.....II-13
Asuragen Introduces Signature® LTx in Markets Worldwide.....II-13
1$100
   Biomatrica Launches PCRboost™ - A New Reagent.....II-14
Genetix Group Launches New CytoGenetix FISH Kits and Reagents.....II-14
1$100
   Strategic Diagnostics Introduces New Online Catalog of Antibody Reagents.....II-15
Bioatlas Expands Bioatlas Product Lineup with Atlas Antifade.....II-15
ScienceXperts & Invitrogen Develop Flow Cytometry Software.....II-15
Beckman Coulter Launches Cell Signal Transduction Reagents.....II-15
1$100
   Sigma-Aldrich Launches LentiExpress™ Technology.....II-16
Abbott Unveils New Assays and Reagents.....II-16
Applied Biosystems Introduces New Master Mix Reagent.....II-16
Promega Designs Advanced Luciferase Assay.....II-16
1$100
   Ortho-Clinical Diagnostics Expands Test-Base for Infectious Diseases.....II-17
Genetix Launches Two Novel ''CloneMedia'' Semi-Solid Media Products.....II-17
Invitrogen Launches Lipofectamine LTX.....II-17
Beckman Coulter Launches IOTest® Anti-Rat Flow Cytometry Reagents.....II-17
1$100
   EMD Biosciences Introduces ProteoPlex® Human Angiogenesis Array.....II-18
AspenBio Pharma Launches New Single-Chain Gonadotropin .....II-18
Ortho-Clinical Diagnostics Launches VITROS® Chemistry Products d%A1c Reagent.....II-18
Beckman Coulter to Launch Access DHEA-S.....II-18
Solulink Introduces ChromaLink.....II-18
1$100
   Cambrex Launches Versalinx Reagents.....II-19
Kreatech Unveils a New Range of Isolation and Labeling Kits.....II-19
Nanogen Launches Enterovirus Analyte Specific Reagent - MGB Alert™.....II-19
Olympus Unveils New Reagent Kit with Single Molecular Fluorescence
  Spectroscopy.....II-19
SAFC Releases Proligo Reagents.....II-19
LI-COR Biosciences Releases New IRDye® Western Kits for Odyssey® System.....II-19
Altor Launches STAR™ Multimer Reagents.....II-19
1$100
   Guava Technologies Launches a New Range of Antibody Reagents.....II-20
Solexa Launches Genome Analysis System.....II-20
Daiichi Unveils New Reagent Kit.....II-20
Beckman Coulter Introduces Cellular Research Reagents .....II-20
ReaMetrix Introduces Accuford.....II-20
TriPath Imaging Unveils ProEx C.....II-20
1$100
   Roche and 454 Life Sciences Launches Genome Sequencer 20 System and Reagents.....II-21
Chinese Academy of Military Medical Sciences Introduces Reagent to Test Drug Resistance
  of HBV.....II-21
SIAL Unveils SYBR Green Extract-N-Amp Tissue PCR Kit.....II-21
Aldrich Introduces LAB Reagents.....II-21
Kreatech Rolls Out RNA ampULSe Amplification and Labeling Kits.....II-21
bioMérieux Launches NucliSens miniMAG and NucliSens Magnetic Extraction
  Reagents.....II-21
Guava Technologies Launches a New Cell Cycle Assay.....II-21
1$100
   U.S. Genomics Introduces Direct miRNA Reagents for Trilogy Platform.....II-22
Dharmacon Inc, Introduces siGENOME(TM) siRNA.....II-22
1$100
   Agencourt Bioscience Introduces RNA Isolation and Purification Kit.....II-23
Caliper Life Sciences in Collaboration with Promega Offers Automation
  Protocols.....II-23
French Researchers Develop Novel Sandwich Immunoassay for Small Molecule
  Study.....II-23
1$100
   Do-Coop Technologies Launches Water-based Nano-Reagent.....II-24
Affymetrix Inc, Collaborates with Invitrogen to Launch Reagents for GeneChip.....II-24
Roche Unveils Amplicor HPV in the US.....II-24
Shimadzu Develops Reagent for Cell-Free Protein Synthesis.....II-24
1$100
   Roche Working on PCR-based Linear Array Test for HPV.....II-25
1$100
  6. Recent Industry Activity.....II-2632 $1300  
   Invitrogen Plans to Acquire Applied Biosystems.....II-26
FASgen and Tetracore Ink Collaboration Agreement.....II-26
Prodesse and Quidel Ink a Co-Commercialization Agreement.....II-26
1$100
   Bexion and MTTI to Collaborate for New Nanovesicle.....II-27
BD Acquires Cytopeia.....II-27
Affymetrix Acquires USB.....II-27
Millipore and Guava Technologies Enter into Collaboration.....II-27
1$100
   Hologic Agrees to Acquire Third Wave.....II-28
Spartan Bioscience and TrimGen Enter into Partnership.....II-28
Multispan & Promega to Co-Develop Assay Tools.....II-28
1$100
   STEMCELL Joins Forces with Geron.....II-29
HistoRx Signs Agreement with Eli Lilly.....II-29
GE Healthcare to Take Over Whatman.....II-29
1$100
   Inverness Takes Over BBI.....II-30
Medical Solutions to Take Over Autogen.....II-30
Sysmex and bioMerieux Agree to Establish a Joint Venture.....II-30
Miltenyi Acquires Medic.....II-30
1$100
   China Medical Acquires Beijing Bio-Ekon.....II-31
Gene Bridges Partners with Mbiotech.....II-31
Roche Acquires Ventana Medical.....II-31
BioMérieux to Shutdown Boxtel Facility.....II-31
1$100
   Abbott Inks Agreement with Premier.....II-32
Beckman Coulter Acquires Dako’s Flow Cytometry Instrumentation Business.....II-32
Cliniqa Acquires the Assets of Reagents Applications.....II-32
Frontier Scientific Acquires Echelon Biosciences.....II-32
1$100
   Immucor Signs Supply Agreement with American Red Cross.....II-33
Ventana Medical Takes Over Spring BioScience.....II-33
TriLink Biotechnologies Inks Agreement with Applied Biosystems.....II-33
Bio-Rad Takes Over DiaMed Holdings.....II-33
1$100
   PerkinElmer Takes Over ViaCell.....II-34
Sigma-Aldrich in Alliance with Sangamo BioSciences.....II-34
Fitzgerald Industries Takes Over Cortex Biochem’s Immunoreagent Business.....II-34
1$100
   Agilent Technologies Acquires Stratagene.....II-35
Dendritic Signs Supply Agreement with EMD Biosciences.....II-35
Spectral Diagnostics Inks Agreement with Bio-Rad.....II-35
Japanese Atol Plans to Acquire a Major Stake in Naha Yakuhin.....II-35
Roche Takes Over NimbleGen.....II-35
1$100
   Roche Takes Over BioVeris.....II-36
Roche Acquires 454 Life Sciences.....II-36
Sysmex & Roche Diagnostics Extend Distribution Agreement.....II-36
Invitrogen and Biocon Inks Exclusive Marketing Agreement.....II-36
1$100
   PerkinElmer Acquires Remaining Stake in PerkinElmer India.....II-37
Promega Enters Into Alliance with Guangzhou Institute.....II-37
Adaltis Acquires Shanghai Hua Tai Biotechnology.....II-37
1$100
   ABR-Affinity Inks Distribution Agreements with Genesis & Good Biotech.....II-38
The PLSG Makes Financial Investment in AIT.....II-38
Numira Merges with Visual Influence.....II-38
Abbott Receives FDA Clearance for CELL-DYN Ruby™.....II-38
1$100
   Tm Bioscience Bags Supply Contract JMC.....II-39
ReaMetrix Receives Clearance for Accuford Tri-T Stat.....II-39
Panomics Establishes New Subsidiary in Europe.....II-39
Promega Completes Benitec Acquisition.....II-39
NCGC Joins Forces with PerkinElmer.....II-39
1$100
   MBL Acquires Antibody Business of LifeSpan BioSciences.....II-40
Sigma-Aldrich and Genospectra Sign a Series of Agreements.....II-40
Nitragin Completes the Acquisition of Agribiotics.....II-40
Fujirebio Diagnostics Acquires CanAg Diagnostics.....II-40
1$100
   Chemicon Inks an Agreement with ASCC .....II-41
Takara Bio. Pharma Acquires Stakes in Takara Biotechnology.....II-41
Millipore Takes Over Serologicals.....II-41
Serologicals Takes Over LINCO.....II-41
Genospectra Merges with Panomics.....II-41
1$100
   Roche Enters into Three-Year Contract with Premier.....II-42
KREATECH and GenTel Enter into Distribution Agreement.....II-42
Kreatech Enters into Supply Agreement with QIAGEN.....II-42
Invitrogen to Provide Reagents for Genome Sequencing of Solexa.....II-42
VWR International to Market Biocare Equipment and Reagents in IHC.....II-42
Biocare Partners with Epitomics for Reagents.....II-42
1$100
   GE and CytoGenix Form an Alliance.....II-43
Fisher Biosciences Joins Forces with Dyomics.....II-43
PerkinElmer Partners with NCGC.....II-43
SAFC-Biosciences Formed to Support Sigma-Aldrich.....II-43
Takara Bio Takes Over Clonetech.....II-43
1$100
   Techne's Subsidiary Pockets BiosPacific and Fortron Bio Science.....II-44
QIAGEN Obtains Nextal.....II-44
Invitrogen Takes Over Caltag.....II-44
Invitrogen Takes Over Biosource International.....II-44
Serologicals Acquires Specialty Media from Sentigen.....II-44
Invitrogen Acquires Zymed Laboratories.....II-44
Biotage Acquires Argonaut Technologies.....II-44
1$100
   Invitrogen Acquires Dynal Biotech.....II-45
Vita and Cortex Biochem Enter into Distribution Agreement.....II-45
SIAL and OXB Sign an Agreement for Commercializing LentiVector Technology.....II-45
Funakoshi and Affibody Sign a Distribution Agreement.....II-45
KREATECH and GenTel Enter into Marketing Agreement.....II-45
KREATECH and Ambion Enter into Supply Agreement.....II-45
1$100
   SIAL Enters into Distribution Agreement with MedAssets.....II-46
IBT Signs Distribution Contracts for Enzymes.....II-46
Epitome Signs a License Agreement with EMD Biosciences.....II-46
Consorta Inks Multiple Agreements with Dade Behring.....II-46
SCS and Chemicon Sign an Agreement for ES Cell Media.....II-46
1$100
   LSBC and BioCatalytics Enter into Collaborative Agreement for Producing
  Enzymes.....II-47
Chemicon International Enters into an Agreement with QDC.....II-47
Dharmacon Signs an Agreement with Genentech.....II-47
Invitrogen Partners with PerkinElmer.....II-47
Chemicon and Axordia Collaborate for New Antibody Markers.....II-47
eGene Enters into Strategic Alliance with Transgenomic.....II-47
1$100
   Cancer Genetics Selects Genetics Specialities.....II-48
Clinical Data Bags Distribution Rights for Hematology Analyzers and Reagents.....II-48
BD Biosciences to Expand Production in Puerto Rico.....II-48
Olympus Enlarges R&D Unit in Ireland.....II-48
Olympus Begins Production of Immunoassay Reagents.....II-48
Koon-wah Leong, Shery Guo and Suyue Qian Produces Multilayer Test Strips.....II-48
1$100
   CMT Sells off Specialty Media Division.....II-49
CSL Divests Cell Culture Reagent Business to Sigma-Aldrich.....II-49
BD Divests Clontech Business .....II-49
Hycor Biomedical Merges with Stratagene Corporation.....II-49
GE Acquires Amersham plc.....II-49
CalbaTech Snaps Up K-D Medical.....II-49
1$100
   Tepnel Life Sciences Acquires Diaclone Research SAS.....II-50
BD Acquires Atto Bioscience.....II-50
Invitrogen to Acquire Bio Asia.....II-50
Idexx Announce Plans to Acquire Switzerland-based Bommeli.....II-50
1$100
   Chemicon Announce Plans to Acquire Product Lines from Primogenix.....II-51
Bio-Rad Laboratories to Acquire MJ GeneWorks.....II-51
D. Lansing Taylor Join Forces with PLSG to Create Cellumen.....II-51
eGene Inc. and Prisma Biotech form Distribution Alliance.....II-51
1$100
   eGene Alliances with HVD Life Science and HVD Biotech Vertriebs-GmbH.....II-52
Cell Signaling Technology, Inc. and Zeptosens AG Sign Licensing Agreement for CST
  reagents.....II-52
Pierce and Tecan Enter into Drug Discovery Covenant.....II-52
1$100
   Syntonix and Dyax Enter into Antibody Discovery Pact.....II-53
NeoPharm Signs an Agreement with Nippon Genetics.....II-53
1$100
   Amersham Signs Distribution Agreement with Guava Technologies II-53 CST and LI-COR
  Sign an Agreement.....II-54
Cell Signaling Technology, Inc. Signs Agreement with ProQinase GmbH.....II-54
Sigma-Aldrich Signs a Distribution Agreement with Avecia.....II-54
1$100
   LSBC and Sigma-Aldrich Enter into Recombinant Aprotinin Agreement.....II-55
Atugen Signs a Contract Research Agreement with Eisai.....II-55
CII Enters into Sub-License Agreement with Promega.....II-55
Dharmacon Signs Agreement with Wyeth Pharmaceuticals.....II-55
SurModics inks Distribution Agreement with SeraCare Life Sciences.....II-55
1$100
   Hydra Biosciences Signs Agreement with Evotec OAI AG.....II-56
Chemicon International Strikes a Deal with Thromb-X N.V......II-56
Ambion Inks Agreement with Applied Biosystems.....II-56
Cosmo Bio Establishes New US Subsidiary.....II-56
1$100
   Agilent Technologies Inc, Establishes Integrated Biology Solutions Unit.....II-57
CeMines Completes Expansion Program.....II-57
1$100
  7. Focus on Select Players Worldwide.....II-585 $500  
   Abbott Diagnostics (USA).....II-58
Applied Biosystems (USA).....II-58
Beckman Coulter, Inc. (USA).....II-58
1$100
   Becton Dickinson and Company (USA).....II-59
BioMérieux SA (France).....II-59
Chemicon International, Inc. (USA).....II-59
1$100
   EMD Biosciences, Inc. (USA).....II-60
Fitzgerald Industries International (USA) .....II-60
GE Healthcare (UK).....II-60
Invitrogen Corporation (US).....II-60
1$100
   Ortho-Clinical Diagnostics (US).....II-61
PerkinElmer, Inc. (US).....II-61
Promega Corporation (US).....II-61
1$100
   Roche Diagnostics Ltd. (Switzerland).....II-62
Siemens Healthcare Diagnostics, Inc. (USA) .....II-62
Sigma – Aldrich (USA).....II-62
1$100
  8. Global Market Perspective.....II-63   
   Table 1: World Recent Past, Current & Future Market Analysis for Biotechnology Reagents by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-631$350
   Table 2: World Long-term Projections for Biotechnology Reagents by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-641$350
   Table 3: World 10-Year Perspective for Biotechnology Reagents by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-651$350
   World Market for Biotechnology Reagents by Product Segment.....II-66
Table 4: World Recent Past, Current & Future Market Analysis for Cell / Tissue Culture Reagents by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-66
1$350
   Table 5: World Long-term Projections for Cell / Tissue Culture Reagents by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-671$350
   Table 6: World 10-Year Perspective for Cell / Tissue Culture Reagents by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-681$350
   Table 7: World Recent Past, Current & Future Market Analysis for DNA Sequencing / Synthesis Reagents by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-691$350
   Table 8: World Long-term Projections for DNA Sequencing / Synthesis Reagents by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-701$350
   Table 9: World 10-Year Perspective for DNA Sequencing / Synthesis Reagents by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-711$350
   Table 10: World Recent Past, Current & Future Market Analysis for Electrophoresis Reagents by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-721$350
   Table 11: World Long-term Projections for Electrophoresis Reagents by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-731$350
   Table 12: World 10-Year Perspective for Electrophoresis Reagents by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-741$350
   Table 13: World Recent Past, Current & Future Market Analysis for Flow Cytometry Reagents by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-751$350
   Table 14: World Long-term Projections for Flow Cytometry Reagents by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-761$350
   Table 15: World 10-Year Perspective for Flow Cytometry Reagents by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-771$350
   Table 16: World Recent Past, Current & Future Market Analysis for Immunoassay Reagents by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-781$350
   Table 17: World Long-term Projections for Immunoassay Reagents by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-791$350
   Table 18: World 10-Year Perspective for Immunoassay Reagents by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-801$350
   Table 19: World Recent Past, Current & Future Market Analysis for Liquid Chromatography Reagents by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-811$350
   Table 20: World Long-term Projections for Liquid Chromatography Reagents by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-821$350
   Table 21: World 10-Year Perspective for Liquid Chromatography Reagents by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-831$350
   Table 22: World Recent Past, Current & Future Market Analysis for Polymerase Chain Reaction Reagents by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-841$350
   Table 23: World Long-term Projections for Polymerase Chain Reaction Reagents by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-851$350
   Table 24: World 10-Year Perspective for Polymerase Chain Reaction Reagents by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-861$350
   Table 25: World Recent Past, Current & Future Market Analysis for Protein Synthesis Reagents by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-871$350
   Table 26: World Long-term Projections for Protein Synthesis Reagents by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-881$350
   Table 27: World 10-Year Perspective for Protein Synthesis Reagents by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-891$350
III. MARKET103$1950
  1. United States.....III-143 $1525  
   A. Market Analysis.....III-1
Biotech Industry in the US.....III-1
Escalating Demand for Biomedical Research Reagents and Kits.....III-1
Application-Oriented Products Herald a Technological Upheaval.....III-1
1$75
   Competition - Highly Prevalent.....III-2
Review of US Cell/Tissue Culture Supplies Market.....III-2
Industrial Segment –Largest End-User.....III-2
1$75
   Rise in Cell Culture Equipment Demand Leads to Innovation.....III-3
Factors Influencing the Market for Media.....III-3
Fetal Bovine Serum - Use on a Decline.....III-3
Table 28: Leading Producers of Fetal Bovine Serum in the US (2004): Percentage Breakdown of Value Sales for Life Technologies, Hyclone, and Others (includes corresponding Graph/Chart).....III-3
1$200
   Suppliers Searching for New Areas.....III-4
Serum Free Products Market: Rapidly Growing.....III-4
Immunoassay Reagents.....III-4
Table 29: Leading Players in the US Immunoassay Reagents Market (2004): Percentage Breakdown of Value Sales (*) for Abbott Diagnostics, Dade Behring, Roche Diagnostics, Beckman Coulter, and Others (includes corresponding Graph/Chart).....III-4
1$200
   Issues Affecting the US Immunodiagnostics Market.....III-5
Technological Innovations Play a Vital Role.....III-5
Chromatography Reagents Market to Register Strong Growth .....III-5
Table 30: US Market for Chromatography Reagents (2007): Percentage Breakdown of Sales of Reagents by Application/Technique (includes corresponding Graph/Chart).....III-5
1$200
   Molecular Biological Reagents.....III-6
Rapidly Growing Market.....III-6
Table 31: Molecular Biology Reagents Market in the US (2004): Percentage Breakdown of Value Sales by End use for Academic User, Biotech industry, Pharmaceuticals, and Government (includes corresponding Graph/Chart).....III-6
DNA Sequencing: Gaining Prominence.....III-6
1$200
   Key Players.....III-74$300
   Product Launches.....III-1110$475
   Strategic Developments.....III-2120$850
   B. Market Analytics.....III-41
Table 32: US Recent Past, Current & Future Analysis for Biotechnology Reagents by Product Segment – Cell/Tissue Culture Reagents, DNA Sequencing/Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-41
1$200
   Table 33: US Long-term Projections for Biotechnology Reagents by Product Segment – Cell/Tissue Culture Reagents, DNA Sequencing/ Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-421$200
   Table 34: US 10-Year Perspective for Biotechnology Reagents by Product Segment – Percentage Breakdown of Dollar Sales for Cell/Tissue Culture Reagents, DNA Sequencing/ Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-43
1$200
  2. Canada.....III-444 $475  
   A. Market Analysis.....III-44
Current & Future Analysis .....III-44
Biotech Sector in Canada.....III-44
Outlook.....III-44
Strategic Developments.....III-44
1$75
   B. Market Analytics.....III-45
Table 35: Canadian Recent Past, Current & Future Analysis for Biotechnology Reagents by Product Segment – Cell/Tissue Culture Reagents, DNA Sequencing/Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-45
1$200
   Table 36: Canadian Long-term Projections for Biotechnology Reagents by Product Segment – Cell/Tissue Culture Reagents, DNA Sequencing/ Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-461$200
   Table 37: Canadian 10-Year Perspective for Biotechnology Reagents by Product Segment – Percentage Breakdown of Dollar Sales for Cell/Tissue Culture Reagents, DNA Sequencing/ Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-47
1$200
  3. Japan.....III-487 $775  
   A. Market Analysis.....III-48
Biotech Scenario.....III-48
1$75
   Outlook.....III-49
Table 38: Japanese Market for Biotechnology (2010F): Percentage Breakdown of Revenues by End-Use Application – Medical Care, Food, Bio Tools & Information, Environment & Energy, and Others (includes corresponding Graph/Chart).....III-49
Product Launches.....III-49
1$200
   Strategic Developments.....III-502$150
   B. Market Analytics.....III-52
Table 39: Japanese Recent Past, Current & Future Analysis for Biotechnology Reagents by Product Segment – Cell/Tissue Culture Reagents, DNA Sequencing/Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-52
1$200
   Table 40: Japanese Long-term Projections for Biotechnology Reagents by Product Segment – Cell/Tissue Culture Reagents, DNA Sequencing/ Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-531$200
   Table 41: Japanese 10-Year Perspective for Biotechnology Reagents by Product Segment – Percentage Breakdown of Dollar Sales for Cell/Tissue Culture Reagents, DNA Sequencing/ Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-54
1$200
  4. Europe.....III-559 $975  
   A. Market Analysis.....III-55
Biotechnology in Europe on an Expansion Spree.....III-55
PCR Technology - An Overview .....III-55
Technological Advancements Drive PCR Market .....III-55
1$75
   Product Launches.....III-56
Strategic Developments.....III-56
2$150
   B. Market Analytics.....III-58
Table 42: European Recent Past, Current & Future Analysis for Biotechnology Reagents by Geographic Region – France, Germany, Italy, UK, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-58
1$200
   Table 43: European Long-term Projections for Biotechnology Reagents by Geographic Region – France, Germany, Italy, UK, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-591$200
   Table 44: European 10-Year Perspective for Biotechnology Reagents by Product Segment – Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, and Rest of Europe for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-601$200
   Table 45: European Recent Past, Current & Future Analysis for Biotechnology Reagents by Product Segment – Cell/Tissue Culture Reagents, DNA Sequencing/Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets for Years 2000, 2005 & 2010 (includes corresponding Graph/Chart).....III-611$200
   Table 46: European Long-term Projections for Biotechnology Reagents by Product Segment – Cell/Tissue Culture Reagents, DNA Sequencing/ Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-621$200
   Table 47: European 10-Year Perspective for Biotechnology Reagents by Product Segment – Percentage Breakdown of Dollar Sales for Cell/Tissue Culture Reagents, DNA Sequencing/ Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-63
1$200
  4a. France.....III-644 $475  
   A. Market Analysis.....III-64
BioMérieux SA – A Key Player .....III-64
Strategic Developments.....III-64
1$75
   B. Market Analytics .....III-65
Table 48: French Recent Past, Current & Future Analysis for Biotechnology Reagents by Product Segment – Cell/ Tissue Culture Reagents, DNA Sequencing/Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-65
1$200
   Table 49: French Long-term Projections for Biotechnology Reagents by Product Segment – Cell/Tissue Culture Reagents, DNA Sequencing/ Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-661$200
   Table 50: French 10-Year Perspective for Biotechnology Reagents by Product Segment – Percentage Breakdown of Dollar Sales for Cell/Tissue Culture Reagents, DNA Sequencing/ Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-67
1$200
  4b. Germany.....III-685 $575  
   A. Market Analysis.....III-68
German Biotech Industry Review.....III-68
Outlook.....III-68
1$75
   Strategic Development .....III-691$75
   B. Market Analytics.....III-70
Table 51: German Recent Past, Current & Future Analysis for Biotechnology Reagents by Product Segment – Cell/Tissue Culture Reagents, DNA Sequencing/Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-70
1$200
   Table 52: German Long-term Projections for Biotechnology Reagents by Product Segment – Cell/Tissue Culture Reagents, DNA Sequencing/ Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-711$200
   Table 53: German 10-Year Perspective for Biotechnology Reagents by Product Segment – Percentage Breakdown of Dollar Sales for Cell/Tissue Culture Reagents, DNA Sequencing/ Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-72
1$200
  4c. Italy.....III-734 $475  
   A. Market Analysis.....III-73
Strategic Development .....III-73
1$75
   B. Market Analytics .....III-74
Table 54: Italian Recent Past, Current & Future Analysis for Biotechnology Reagents by Product Segment – Cell/Tissue Culture Reagents, DNA Sequencing/Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-74
1$200
   Table 55: Italian Long-term Projections for Biotechnology Reagents by Product Segment – Cell/Tissue Culture Reagents, DNA Sequencing/ Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-751$200
   Table 56: Italian 10-Year Perspective for Biotechnology Reagents by Product Segment – Percentage Breakdown of Dollar Sales for Cell/Tissue Culture Reagents, DNA Sequencing/ Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-76
1$200
  4d. The United Kingdom.....III-776 $650  
   A. Market Analysis.....III-77
Research Entities.....III-77
Commercial Activities.....III-77
1$75
   GE Healthcare – A Key Player III-76 Product Launches .....III-78
Strategic Developments .....III-78
2$150
   B. Market Analytics.....III-80
Table 57: UK Recent Past, Current & Future Analysis for Biotechnology Reagents by Product Segment – Cell/Tissue Culture Reagents, DNA Sequencing/Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-80
1$200
   Table 58: UK Long-term Projections for Biotechnology Reagents by Product Segment – Cell/Tissue Culture Reagents, DNA Sequencing/ Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-811$200
   Table 59: UK 10-Year Perspective for Biotechnology Reagents by Product Segment – Percentage Breakdown of Dollar Sales for Cell/Tissue Culture Reagents, DNA Sequencing/ Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-82
1$200
  4e. Rest of Europe.....III-838 $625  
   A. Market Analysis.....III-83
Medical Device Market in Spain.....III-83
Russian Clinical Diagnostic Equipment and Supplies Market.....III-83
Major Reagent Producers.....III-83
Roche Diagnostics Ltd. (Switzerland) – A Key Player .....III-83
1$75
   Product Launches .....III-841$75
   Strategic Developments.....III-853$225
   B. Market Analytics.....III-88
Table 60: Rest of Europe (*) Market for Biotechnology Reagents - Recent Past, Current & Future Analysis by Product Segment for Cell/Tissue Culture Reagents, DNA Sequencing/Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-88
1$200
   Table 61: Rest of Europe Long-term Projections for Biotechnology Reagents by Product Segment – Cell/Tissue Culture Reagents, DNA Sequencing/ Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-891$200
   Table 62: Rest of Europe 10-Year Perspective for Biotechnology Reagents by Product Segment – Percentage Breakdown of Dollar Sales for Cell/Tissue Culture Reagents, DNA Sequencing/ Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-90
1$200
  5. Asia-Pacific.....III-918 $675  
   A. Market Analysis.....III-91
Biotechnology- A Burgeoning Market.....III-91
Impact of IPR on Biotechnology Market.....III-91
Asia-Pacific – A Lucrative R&D Base.....III-91
1$75
   Focus on Key Biotechnology Markets.....III-92
India.....III-92
China .....III-92
1$75
   Korea.....III-93
Clinical Lab Products Market in Korea.....III-93
Product Launches.....III-93
Strategic Developments.....III-93
3$225
   B. Market Analytics.....III-96
Table 63: Asia-Pacific Market for Biotechnology Reagents - Recent Past, Current & Future Analysis by Product Segment for Cell/Tissue Culture Reagents, DNA Sequencing/Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-96
1$200
   Table 64: Asia-Pacific Long-term Projections for Biotechnology Reagents by Product Segment – Cell/Tissue Culture Reagents, DNA Sequencing/ Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-971$200
   Table 65: Asia-Pacific 10-Year Perspective for Biotechnology Reagents by Product Segment – Percentage Breakdown of Dollar Sales for Cell/Tissue Culture Reagents, DNA Sequencing/ Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-98
1$200
  6. Latin America.....III-995 $750  
   A. Market Analysis.....III-99
The Brazilian Biotech Industry: An Overview .....III-99
Table 66: Biotechnology Industry in Brazil (2004): Percentage Breakdown of Revenues Generated by State (includes corresponding Graph/Chart) .....III-99
1$200
   Table 67: Biotechnology Industry in Brazil (2004): Percentage Breakdown by End-Use Sector - Human Health, Government & International Biotechnology Companies, Consumables Suppliers, Equipment, Agribusiness, Animal Health, and Environment (includes corresponding Graph/Chart) .....III-1001$200
   B. Market Analytics.....III-101
Table 68: Latin American Market for Biotechnology Reagents - Recent Past, Current & Future Analysis by Product Segment for Cell/Tissue Culture Reagents, DNA Sequencing/Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-101
1$200
   Table 69: Latin American Long-term Projections for Biotechnology Reagents by Product Segment – Cell/Tissue Culture Reagents, DNA Sequencing/ Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-1021$200
   Table 70: Latin American 10-Year Perspective for Biotechnology Reagents by Product Segment – Percentage Breakdown of Dollar Sales for Cell/Tissue Culture Reagents, DNA Sequencing/ Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-1031$200
IV. COMPETITIVE LANDSCAPE 547$995
  
Total Companies Profiled: 269 (including Divisions/Subsidiaries - 326)

Region/Country                 Players


The United States                194
Canada                            10 
Japan                              6
Europe                            96
     France                        6
     Germany                      22
     The United Kingdom           26
     Italy                        11
     Spain                         2
     Rest of Europe               29
Asia-Pacific (Excluding Japan)    18
Latin America                      2
Click here to request a full table of contents and more details on this project.		  
 
 
Due to the proprietary nature, our previews are offered only to manufacturers, top-tier management consultants, investment banks, and investment research groups.

© Copyrights 2010, Global Industry Analysts, Inc., USA.